RUMORED BUZZ ON CONOLIDINE

These benefits, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the principle of targeting ACKR3 as a novel approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-connected Ailments.By ticking this box and distributing th